Related Experiment Videos
Response to 'Response to 'Chemical burns: Diphoterine untangled' by KS Alexander [Burns 2017]'
K Skaria Alexander1, Jason Wasiak2, Heather Cleland1
1Victorian Adult Burns Service, The Alfred Hospital, Melbourne, Victoria, Australia.
Burns : Journal of the International Society for Burn Injuries
|February 5, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bioengineered Skin from a Platelet-Derived Hydrogel Repairs Full Thickness Wounds in a Pre-Clinical Mouse Model.
International journal of molecular sciences·2025
Burn-Specific Venous Thromboembolism Prophylaxis: A 2-Year Quality Improvement Project.
Journal of burn care & research : official publication of the American Burn Association·2025
Management of operating theatre ambient temperature for major burn patients in a state-wide adult burns centre.
Burns : journal of the International Society for Burn Injuries·2024
Burden and Costs of Severe Burn Injury in Victoria, Australia.
European burn journal·2024
Post-burn Occupational Disruption:Employment Status, Job Change, and Perceived Career Impact.
Burns : journal of the International Society for Burn Injuries·2026
Hyper-inflammatory response in burn patients coincides with impaired antibacterial activity of neutrophils in blood and burn tissue.
Burns : journal of the International Society for Burn Injuries·2026
Neurocognitive outcomes in survivors of severe burn injuries: A systematic review.
Burns : journal of the International Society for Burn Injuries·2026
Pain trajectories during acute hospitalization after burn injuries.
Burns : journal of the International Society for Burn Injuries·2026
Early fluid resuscitation and 28-day mortality in burns: A mediation analysis via coagulation biomarkers.
Burns : journal of the International Society for Burn Injuries·2026
The burden of tobacco-free nicotine dependence in burn survivors: Acute complications and long-term morbidity.
Burns : journal of the International Society for Burn Injuries·2026
Donanemab for early symptomatic AD in the UK-indicated population: safety and efficacy in those who are non-carriers or heterozygous for APOE ε4.
Neurodegenerative disease management·2026